Institutional investors purchased a net $3.5 million shares of SYN during the quarter ended September 2015 and now own 18.48% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 52.0 Thousand shares of Synthetic Biologics Inc